Sofia Guerra joins Bessemer as Partner to lead Health AI practice

Bessemer Venture Partners has elevated Sofia Guerra to the role of Partner, a move that formalises her leadership of the firm’s health‑tech investing and research agenda. Guerra, who joined the firm five years ago, will broaden Bessemer’s activity across healthcare AI, benchmarks and founder engagement.

During her tenure, Sofia Guerra has combined direct deal work with market‑level analysis: she helped build the firm’s signature health tech benchmarking series and led the development of the Healthcare AI Adoption Index. Those pieces of research have become reference points for founders, corporate buyers and fellow investors navigating a sector that analysts expect to scale rapidly as AI tools push into clinical workflows and administrative systems.

Steve Kraus, a Partner at Bessemer Venture Partners, praised Guerra’s judgement and founder rapport, saying she brings clear decision‑making and steady leadership to complex, regulated company builds. Colleagues point to her blend of strategic perspective and operational focus when working with management teams in reimbursement‑intensive markets.

Guerra’s deal experience spans investments and board roles in startups focused on operational and clinical software. She played a sourcing and portfolio role on investments that include names such as PrismTPO, Zingage and Pivotal Health, and backed early companies that later attracted strategic or private equity buyers — for example, an investment that ultimately exited to New Mountain Capital. That mix of outcomes underscores the crossover potential in health tech between venture and later‑stage investors.

Industry context: healthcare AI and adjacent software categories are drawing heavier capital and commercial interest. Market research and investor surveys consistently show rising procurement activity from hospitals and payors, especially for tools that improve revenue cycle efficiency, diagnostics throughput and clinician workflow. For venture firms, the challenge is balancing long commercialization cycles with the need to support founders through clinical validation, contracting and regulatory milestones.

The promotion signals a strategic bet by Bessemer Venture Partners on continued opportunity at the intersection of AI and regulated healthcare. Guerra — originally from Guatemala and an immigrant to the U.S. — has framed her work around championing under‑recognized founders and building repeatable go‑to‑market playbooks for complex markets. As Partner, she will expand the firm’s health tech coverage, deepen founder support and continue publishing the research that helps the broader ecosystem benchmark progress.